Scotspas P Tablet: Your High-Demand PCD Pharma Franchise in Pain Management

About Dicyclomine 20 mg + Paracetamol 325 mg: A Dual-Action Solution

Tapping into the Widespread Market for Spasmodic Pain Relief

Why Scotspas P Tablet is a High-Profit Opportunity for Distributors

Partnering for Success with a Quality-Assured Product
Join Our Pharma Franchise for Unmatched Business Support

Home/Products /dicyclomine-20-mg-paracetamol-325-mg-tablet

Scotspas P Tablet

Composition : Dicyclomine 20mg + Paracetamol 325mg tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹59/-

Scotspas P Tablet is a highly effective combination medication containing Dicyclomine 20 mg and Paracetamol 325 mg, designed to provide rapid and comprehensive relief from spasmodic pain. Dicyclomine acts as a powerful antispasmodic, targeting the smooth muscles of the stomach and intestines to relieve muscle contractions and cramps. Complementing this action, Paracetamol works as a fast-acting analgesic, blocking the chemical messengers in the brain that transmit pain signals. This synergistic formulation makes Scotspas P a go-to solution for a variety of conditions, including abdominal pain, menstrual cramps (dysmenorrhea), and pain associated with Irritable Bowel Syndrome (IBS) and other gastrointestinal disorders.

The market for pain management and gastrointestinal drugs is one of the largest and most consistently stable segments in the Indian pharmaceutical industry. The high prevalence of lifestyle-related and chronic pain conditions ensures a continuous demand for a reliable and effective product like Scotspas P Tablet. This medication is a staple for general practitioners, gastroenterologists, and gynecologists, ensuring a steady flow of prescriptions. Its broad therapeutic application and high-turnover nature make it a strategic and highly profitable addition to any B2B pharma portfolio.

We are dedicated to empowering our franchise partners with all the tools necessary for success in this competitive market. Our product is manufactured in a WHO-GMP certified facility, ensuring impeccable quality, efficacy, and safety, which is crucial for building trust with healthcare professionals. We provide a complete promotional and marketing kit, including detailed product literature, to support your sales efforts. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this stable and highly profitable market and establish a reputable and successful business as a key supplier of this top-quality medicine.

Read More

About the Product

Scotspas P Tablet is a highly effective combination medication containing Dicyclomine 20 mg and Paracetamol 325 mg, designed to provide rapid and comprehensive relief from spasmodic pain. Dicyclomine acts as a powerful antispasmodic, targeting the smooth muscles of the stomach and intestines to relieve muscle contractions and cramps. Complementing this action, Paracetamol works as a fast-acting analgesic, blocking the chemical messengers in the brain that transmit pain signals. This synergistic formulation makes Scotspas P a go-to solution for a variety of conditions, including abdominal pain, menstrual cramps (dysmenorrhea), and pain associated with Irritable Bowel Syndrome (IBS) and other gastrointestinal disorders.

The market for pain management and gastrointestinal drugs is one of the largest and most consistently stable segments in the Indian pharmaceutical industry. The high prevalence of lifestyle-related and chronic pain conditions ensures a continuous demand for a reliable and effective product like Scotspas P Tablet. This medication is a staple for general practitioners, gastroenterologists, and gynecologists, ensuring a steady flow of prescriptions. Its broad therapeutic application and high-turnover nature make it a strategic and highly profitable addition to any B2B pharma portfolio.

We are dedicated to empowering our franchise partners with all the tools necessary for success in this competitive market. Our product is manufactured in a WHO-GMP certified facility, ensuring impeccable quality, efficacy, and safety, which is crucial for building trust with healthcare professionals. We provide a complete promotional and marketing kit, including detailed product literature, to support your sales efforts. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this stable and highly profitable market and establish a reputable and successful business as a key supplier of this top-quality medicine.

May include dry mouth, dizziness, nausea, blurred vision, or drowsiness. Rarely, allergic reactions or constipation may occur. Excessive use may affect liver function (due to Paracetamol).

Abdominal pain and cramps Spastic colic and gastrointestinal discomfort Menstrual cramps (dysmenorrhea) Irritable Bowel Syndrome (IBS) Use only under medical guidance.

Avoid alcohol and other hepatotoxic drugs during use. Use with caution in patients with liver or kidney impairment, glaucoma, or urinary retention. Do not exceed the prescribed dose. Not recommended during pregnancy or lactation unless advised by a physician.

Store below 25°C in a cool, dry place away from sunlight. Keep out of reach of children. Protect from moisture.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation